Octapharma has reportedly presented an update on the clinical development and pre-clinical data of SubQ-8 in a conference at the International Society on Thrombosis and Haemostasis Congress 2019. SubQ-8 integrates a human cell line-derived ....

Though financial details about the deal have not been disclosed, experts opine that it will amount to tens of millions of euros. Froneri, the renowned ice cream manufacturer, reportedly entered the Israeli market by acquiring Noga Ice Crea....

Onco360 will be able to support specialized needs of RRMM patients and their physicians across all the U.S. states The largest independent oncology pharmacy in U.S., Onco360 recently announced that Karyopharm has selected the company as a ....

The innovaTIL-04 study is anticipated to register a total of 75 to 100 patients with the aim to support a BLA submission Reports confirm that Iovance Biotherapeutics, Inc., a biotech company, has recently provided update regarding the regu....

The agreement gives Grupo RPH exclusive right to manufacture and distribute the TLX591-Cdx in the Latin American market Clinical-stage biopharmaceutical firm Telix Pharmaceutical has reportedly signed a manufacturing and distribution agree....

It had earlier informed it will withdraw its investment in Arrow Pharmaceuticals for an agreed price of AUD 394 million Reports confirm that Strides Pharma Science, a Bangalore based pharmaceutical company, has recently announced that....

The 26-week observational study included 16 subjects at three different hospitals in the UK Global regenerative medicine company AVITA Medical has recently announced that their open-label study of the latest RECELL® System, conducted o....

The companies will combine their solution and insights to improve manufacturing productivity Accenture, a multinational services company, recently announced that it is going to collaborate with Mujin, manufacturer of industrial robot contr....

The Hero Cycles project is scheduled to start manufacturing operations from October 2020 Global bicycle giant Fushida Group has recently announced its partnership with Hero Cycles for a ₹210 crore worth project in the hi-tech cycle ....

Controlled IL-12 platform from Ziopharm is an investigational gene therapy designed to control and induce human interleukin 12 production Ziopharm Oncology Inc, a company that focuses on developing cell therapies and immune-oncology gene, ....